Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

被引:746
作者
Wang, KC
Koprivica, V
Kim, JA
Sivasankaran, R
Guo, Y
Neve, RL
He, ZG
机构
[1] Childrens Hosp, Div Neurosci, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA
[3] Aventis Pharmaceut, Bridgewater, NJ 08807 USA
[4] McLean Hosp, Belmont, MA 02478 USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
D O I
10.1038/nature00867
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The inhibitory activity associated with myelin is a major obstacle for successful axon regeneration in the adult mammalian central nervous system (CNS)(1,2). In addition to myelin-associated glycoprotein (MAG)(3,4) and Nogo-A(5-7), available evidence suggests the existence of additional inhibitors in CNS myelin(8). We show here that a glycosylphosphatidylinositol (GPI)-anchored CNS myelin protein, oligodendrocyte-myelin glycoprotein (OMgp), is a potent inhibitor of neurite outgrowth in cultured neurons. Like Nogo-A, OMgp contributes significantly to the inhibitory activity associated with CNS myelin. To further elucidate the mechanisms that mediate this inhibitory activity of OMgp, we screened an expression library and identified the Nogo receptor (NgR)(9) as a high-affinity OMgp-binding protein. Cleavage of NgR and other GPI-linked proteins from the cell surface renders axons of dorsal root ganglia insensitive to OMgp. Introduction of exogenous NgR confers OMgp responsiveness to otherwise insensitive neurons. Thus, OMgp is an important inhibitor of neurite outgrowth that acts through NgR and its associated receptor complex. Interfering with the OMgp/NgR pathway may allow lesioned axons to regenerate after injury in vivo.
引用
收藏
页码:941 / 944
页数:5
相关论文
共 23 条
[1]   Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 [J].
Chen, MS ;
Huber, AB ;
van der Haar, ME ;
Frank, M ;
Schnell, L ;
Spillmann, AA ;
Christ, F ;
Schwab, ME .
NATURE, 2000, 403 (6768) :434-439
[2]   EFFECTS OF BRAIN-DERIVED NEUROTROPHIC FACTOR ON OPTIC AXON BRANCHING AND REMODELING IN-VIVO [J].
COHENCORY, S ;
FRASER, SE .
NATURE, 1995, 378 (6553) :192-196
[3]   Alkaline phosphatase fusion proteins for molecular characterization and cloning of receptors and their ligands [J].
Flanagan, JG ;
Cheng, HJ .
APPLICATIONS OF CHIMERIC GENES AND HYBRID PROTEINS PT B: CELL BIOLOGY AND PHYSIOLOGY, 2000, 327 :198-210
[4]   Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration [J].
Fournier, AE ;
GrandPre, T ;
Strittmatter, SM .
NATURE, 2001, 409 (6818) :341-346
[5]   Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein [J].
GrandPré, T ;
Nakamura, F ;
Vartanian, T ;
Strittmatter, SM .
NATURE, 2000, 403 (6768) :439-444
[6]  
Habib AA, 1998, J NEUROCHEM, V70, P1704
[7]   Neuropilin is a receptor for the axonal chemorepellent Semaphorin III [J].
He, ZG ;
TessierLavigne, M .
CELL, 1997, 90 (04) :739-751
[8]   Regenerating the damaged central nervous system [J].
Horner, PJ ;
Gage, FH .
NATURE, 2000, 407 (6807) :963-970
[9]   A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord [J].
Huang, DW ;
McKerracher, L ;
Braun, PE ;
David, S .
NEURON, 1999, 24 (03) :639-647
[10]   Semaphorin-mediated axonal guidance via Rho-related G proteins [J].
Liu, BP ;
Strittmatter, SM .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (05) :619-626